NYSE · Health Care

CVS HEALTH CORP CVS

CVS Health is a leading health solutions company in the United States, spanning pharmacy services and health insurance. Total revenue in the fourth quarter of 2025 increased by 8.2% year-on-year, but operating profit declined slightly due to rising costs. Investment analysis needs to focus on the integration effect of its pharmacy and insurance businesses and its ability to control medical expenses.

Pharmacy / Insurance

Company profile

Business mix

  • Pharmacy benefit management, retail pharmacy, long-term care pharmacy, health insurance (Aetna) and pharmaceutical retail, etc.
  • The company covers nearly 10,000 stores and tens of millions of members across the United States through brands such as CVS Pharmacy, Caremark and Aetna.

Current key questions

  • Revenue growth and profit margin compression coexisted. Q4 operating profit fell by 10.8% year-on-year, and adjusted operating profit fell by 4.8%.
  • Although diluted earnings per share increased significantly by 76.9% year-on-year to US$2.30, attention should be paid to the impact of non-recurring items on earnings quality.
  • The risk of rising medical loss ratios (MLR) and drug pricing pressure may continue to squeeze insurance business profits.
  • Retail pharmacies face online competition and changes in customer traffic, and same-store sales growth in 2025 remains to be verified.
Holders 6 Current sample portfolio
Public mentions 0 Videos / interviews / letters
Valuation snapshot
PE 41.79 FCF 6.04% Buyback -1.07%
2026-06-07

Current firm holders

Firm Weight Value Filing period
Davis Advisors Chris Davis 4.0% $879.1M 2026-03-31
Glenview Capital Management Larry Robbins 14.8% $588.7M 2026-03-31
Fairfax Financial Prem Watsa 10.0% $194.8M 2026-03-31
Ariel Investments John Rogers 0.6% $50.4M 2026-03-31
Bridgewater Associates Ray Dalio 0.2% $44.4M 2026-03-31
Tweedy, Browne Company 0.1% $1.4M 2026-03-31

Recent trading changes over the last 1 quarters

Net buyers 1 Last 1 13F filing periods
Net reducers 5 Last 1 13F filing periods
Unchanged holders 2 Share count unchanged
Increase amount $506,115 Estimated from net added shares
Reduction amount $636.8M Estimated from net reduced shares
Net share change / base shares -25.8% -8,792,432 / 34,124,657
Bridgewater Associates Ray Dalio 1 filing periods
13F 2026-03-31 Filed 2026-05-15
Major reduction Shares -40.4% 13F value change -$37.9M
Settlement As of 13F 2026-03-31 · Filed 2026-05-15
Base shares 1,037,352 Last 1 periods -418,924 (-40.4%) Total shares 618,428 Value $44.4M
Fairfax Financial Prem Watsa 1 filing periods
13F 2026-03-31 Filed 2026-05-15
Unchanged Shares 0.0% 13F value change $0
Settlement As of 13F 2026-03-31 · Filed 2026-05-15
Base shares 2,712,000 Last 1 periods +0 (0.0%) Total shares 2,712,000 Value $194.8M
Glenview Capital Management Larry Robbins 1 filing periods
13F 2026-03-31 Filed 2026-05-15
Unchanged Shares 0.0% 13F value change $0
Settlement As of 13F 2026-03-31 · Filed 2026-05-15
Base shares 8,196,799 Last 1 periods +0 (0.0%) Total shares 8,196,799 Value $588.7M
Sachem Head Capital Management Scott Ferguson 1 filing periods
13F 2026-03-31 Filed 2026-05-15
Sold out Shares -100.0% 13F value change -$205.1M
Settlement As of 13F 2026-03-31 · Filed 2026-05-15
Base shares 2,585,000 Last 1 periods -2,585,000 (-100.0%) Total shares 0 Value $0
Ariel Investments John Rogers 1 filing periods
13F 2026-03-31 Filed 2026-05-14
Minor reduction Shares -14.9% 13F value change -$15.1M
Settlement As of 13F 2026-03-31 · Filed 2026-05-14
Base shares 825,092 Last 1 periods -122,941 (-14.9%) Total shares 702,151 Value $50.4M
Davis Advisors Chris Davis 1 filing periods
13F 2026-03-31 Filed 2026-05-07
Minor reduction Shares -4.1% 13F value change -$133.6M
Settlement As of 13F 2026-03-31 · Filed 2026-05-07
Base shares 12,760,511 Last 1 periods -520,845 (-4.1%) Total shares 12,239,666 Value $879.1M
Tweedy, Browne Company 1 filing periods
13F 2026-03-31 Filed 2026-05-06
Major increase Shares 58.3% 13F value change +$414,994
Settlement As of 13F 2026-03-31 · Filed 2026-05-06
Base shares 12,085 Last 1 periods +7,047 (+58.3%) Total shares 19,132 Value $1.4M
Oakmark / Harris Associates Bill Nygren 1 filing periods
13F 2025-06-30 Filed 2025-08-14
Major reduction Shares -85.9% 13F value change -$348.0M
Settlement As of 13F 2025-06-30 · Filed 2025-08-14
Base shares 5,995,818 Last 1 periods -5,151,769 (-85.9%) Total shares 844,049 Value $58.2M

Recent mentions

No public mentions.